1. Market Research
  2. > Media
  3. > Publishing Market Trends
  4. > Loestrin 24 Fe-Drug Insights, 2015

Loestrin 24 Fe-Drug Insights, 2015

  • April 2015
  • -
  • Delve Insight

SUMMARY
DelveInsight’s pharmaceuticals report, “Loestrin 24 Fe- Drug Insights, 2015” highlights the Loestrin 24 Fe marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the “Loestrin 24 Fe covering the total sales estimation for the countries in which the drug is approved and also provides the Loestrin 24 Fesales performance during the forecast period (2012-2016). DelveInsight’s Report has also covered the detailed clinical assessment of the “Loestrin 24 Fe, detailed patents information and market exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report is also providing the SWOT analysis for the Loestrin 24 Fe.


Data Sources

DelveInsight’s pharmaceuticals report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.


Scope

- A review of the Loestrin 24 Fe based on information derived from company and industry-specific sources
- Coverage of the Marketed data of the Loestrin 24 Fe on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
- Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Loestrin 24 Fe with location details
- Patent Expiry Timeline and Exclusivity Details
- Route of Synthesis of the API
- Global Forecasted Sales Figure from 2012-2016
- Qualitative and quantitative assessment of market space
- SWOT Analysis


Reasons to buy


- Evaluate the marketing status and exclusivity details of Loestrin 24 Fe to exploit opportunities for generic drug development opportunities.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Loestrin 24 Fe.
- API intelligence over Loestrin 24 Fe and gaining primary intelligence over Active Ingredients manufacturers across the globe.
- Understanding the chemical route of synthesis ofLoestrin 24 Fe.
- Uncovering opportunities in the rapidly growing the US market
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Obtain sales forecast for currently marketed drug for 2012-2016

Table Of Contents

Loestrin 24 Fe-Drug Insights, 2015
Table of Contents

- Drug Overview
- Global Sales Assessment
- Product Description
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
- Marketed Details for the United States
- Marketed Details for theEurope
- Patent Information
- Patent and Exclusivity Expiry Assessment United States (US)
- Patent Numbers and Expiry Details
- Patent Details
- Route of Synthesis
- Global API Manufacturers Assessment
- The United States Drug Master File (US DMF)
- The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
- The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
- The Active Pharmaceutical Ingredient (API) Manufacturers by Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
- Generic Players
- The Pipeline Coverage
- Clinical Trials Information
- Clinical Trials by Zone
- Company Profile
- Summary
- Company Financials
- SWOT Analysis
- References
- Appendix
- Methodology
- About DelveInsight
- Contact Us
- Disclaimer


List of Tables

- Loestrin 24 Fe, Market, Global Sales (in USD), 2015
- Loestrin 24 Fe, Description
- Loestrin 24 Fe, Marketed Details the United States (US)
- Loestrin 24 Fe, Marketed Details the Europe (EU)
- Loestrin 24 Fe, Patent/Exclusivity Expiry (Year), 2015
- Loestrin 24 Fe, Patent Number Specific Patent Expiry (Year), 2015
- Loestrin 24 Fe, Patent Details
- Loestrin 24 Fe, Route of Synthesis
- Loestrin 24 Fe, the United States Drug Master File (US DMF), 2015
- Loestrin 24 Fe, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2015
- Loestrin 24 Fe, the API Manufacturers, China, 2015
- Loestrin 24 Fe, the API Manufacturers, India, 2015
- Loestrin 24 Fe, the API Manufacturers by the US DMF Status, 2015
- Loestrin 24 Fe, the API Manufacturers by Region, 2015
- Loestrin 24 Fe, the API Manufacturers by Location/Countries, 2015
- Loestrin 24 Fe, Generic Players, 2015
- Loestrin 24 Fe, Pipeline Drug Details, 2015
- Loestrin 24 Fe, Clinical Trials, 2015
- Loestrin 24 Fe, Clinical Trials by Zone, 2015
- Company Overview, 2015
- Loestrin 24 Fe, SWOT Analysis, 2015
- Phase III Pipeline Therapeutics, 2015


List of Figures

- Loestrin 24 Fe,Market, Global Sales (in million USD), 2015
- Loestrin 24 Fe, Global Sales % Change, 2015
- Loestrin 24 Fe, Patent/Exclusivity Expiry (Year), 2015
- Loestrin 24 Fe, Patent Number Specific Patent Expiry (Year), 2015
- Loestrin 24 Fe, Route of synthesis
- Loestrin 24 Fe, the API Manufacturers by the US DMF Status (%), 2015
- Loestrin 24 Fe, the API Manufacturers by Region, 2015
- Loestrin 24 Fe, the API Manufacturers by Location/Countries, 2015
- Loestrin 24 Fe, Generic Players, 2015
- Loestrin 24 Fe, Clinical Trials by Zone (%), 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Malt-based Ingredients: Global Market Intelligence (2011-2020)

Malt-based Ingredients: Global Market Intelligence (2011-2020)

  • $ 4675
  • Industry report
  • November 2016
  • by Sprout Intelligence

REPORT OBJECTIVES The report “Malt-based Ingredients: Global Market Intelligence (2011-2020)” provides market intelligence on the different market segments, based on type, form, grade, application ...

Fermentation Ingredients: Global Market Intelligence (2011-2020)

Fermentation Ingredients: Global Market Intelligence (2011-2020)

  • $ 4675
  • Industry report
  • November 2016
  • by Sprout Intelligence

REPORT OBJECTIVES The report “Fermentation Ingredients: Global Market Intelligence (2011-2020)” provides market intelligence on the different market segments, based on type, application, and geography. ...

Rendered Products: Global Market Intelligence (2011-2020)

Rendered Products: Global Market Intelligence (2011-2020)

  • $ 4675
  • Industry report
  • November 2016
  • by Sprout Intelligence

REPORT OBJECTIVES The report “Rendered Products: Global Market Intelligence (2011-2020)” provides market intelligence on the different market segments, based on type, source, application, and geography. ...

Media Global Market Report 2017

December 2016 $ 4000

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.